What to expect at the 2018 AGITG Annual Scientific Meeting
The Australasian Gastro-Intestinal Trials Group (AGITG) is the only research organisation in the Australasian region with a focus... Read More
New numbers from AIHW released for Colorectal and Digestive-tract cancers
A first-of-its-kind report from the Australian Institute of Health and Welfare (AIHW) provides a new understanding of all... Read More
John Zalcberg & Chris Jackson call for access to treatment for New Zealand cancer patients
Professor John Zalcberg and the director of the New Zealand Cancer Society, Chris Jackson, have called for a... Read More
AGITG Trial News
Trial news: The AGITG currently has twelve studies open to recruitment and four studies in follow up. The table below... Read More
How the GI Cancer Institute’s research is developed
The GI Cancer Institute’s research and clinical trials are developed through a robust, scientific process. The studies we... Read More
Cutting-edge trial using stereotactic body radiotherapy in addition to modern chemotherapy to kill pancreatic cancer
Pancreatic cancer could be treated using a new form of radiotherapy that delivers highly targeted doses of radiation... Read More
AGITG Outstanding Site Award
The deadline for the AGITG Outstanding Site Award had been extended to Friday 28 September. Clinical trial sites... Read More
CAP member Brian Wall awarded Honorary Doctorate of Science
Brian Wall, a member of the GI Cancer Institute’s Consumer Advisory Panel, was awarded an Honorary Doctorate of... Read More
Blood tests could detect cancer DNA: The DYNAMIC-Pancreas trial
Pancreatic cancer is aggressive and has few long-term survivors. Long-term survival can only be achieved by surgically removing... Read More
John Zalcberg & Chris Jackson call for access to treatment for New Zealand cancer patients
Professor John Zalcberg and the director of the New Zealand Cancer Society, Dr Chris Jackson, have called for... Read More
Dietitian Katie Benton: ‘Nutrition plays such a key role’ in patient care
Katie Benton is a dietitian specialising in cancer nutrition who has been working in the area of GI... Read More
Recruitment continues for ACTICCA-1
The AGITG’s ACTICCA-1 trial is studying the best treatment for patients with biliary tract cancer, known as cholangiocarcinoma. Biliary... Read More
NETs forum: Creating a space for discussion of a rare and complex disease
Neuroendocrine tumours are a rare form of cancer – living with this disease can be isolating. On Sunday,... Read More
2018 AGITG Innovation Fund – Applications now closed
The AGITG Innovation Fund is made possible through generous contributions from the Spencer Gibson Foundation, the... Read More
CAP members Gill Worden & Jan Mumford: Going above and beyond for research
Gill Worden & Jan Mumford, members of the AGITG’s Consumer Advisory Panel (CAP), will both trek 60km for... Read More
Gastrointestinal Stromal Tumour Trials and Regorafenib Access Program
This information was prepared for AGITG members by Professor Desmond Yip and Professor John Zalcberg. There are now a... Read More
Our Research Priorities: What is key to the future of research?
During 2017 our Board of Directors and management created a revised Strategic Plan for the organisation and its... Read More
DYNAMIC-Rectal: Using blood tests to make chemotherapy decisions
The DYNAMIC-Rectal trial has opened to recruitment. This trial is analysing the presence of circulating tumour DNA (ctDNA)... Read More
Dr Danielle Ferraro: How the Kristian Anderson Award enabled my research
Dr Danielle Ferraro from the University of Melbourne was the recipient of the inaugural Merck-AGITG Kristian Anderson Award... Read More
ICECREAM trial results published
ICECREAM trial results published The results of the ICECREAM trial have been published in the journal Clinical Colorectal... Read More